1. Volume 165, Issue 5, Pages 1481-1487 (May 2001)
BILHARZIAL RELATED, ORGAN CONFINED, MUSCLE INVASIVE BLADDER CANCER: PROGNOSTIC VALUE OF APOPTOSIS MARKERS, PROLIFERATION MARKERS, p53, E-CADHERIN, EPIDERMAL GROWTH FACTOR RECEPTOR AND c- erbB-2 
ANDREA HAITEL, BERND POSCH, MAHMOUD EL-BAZ, ALAA A. MOKHTAR, MARTIN SUSANI, MOHAMED A. GHONEIM, MICHAEL MARBERGER 
The Journal of Urology 
Volume 165, Issue 5, Pages (May 2001)
DOI: /S (05)66332-X
Copyright © 2001 American Urological Association, Inc. Terms and Conditions

2. Fig. 1
Kaplan-Meier disease-free survival curves for transitional cell carcinoma (TCC) versus squamous cell carcinoma (SCC) (log-rank test p = ).
The Journal of Urology  , DOI: ( /S (05)66332-X)
Copyright © 2001 American Urological Association, Inc. Terms and Conditions

3. Fig. 2
Kaplan-Meier disease-free survival curves for Bak negative versus Bak positive in squamous cell carcinoma (log-rank test p = 0.039).
The Journal of Urology  , DOI: ( /S (05)66332-X)
Copyright © 2001 American Urological Association, Inc. Terms and Conditions

4. Fig. 3
Kaplan-Meier disease-free survival curves for Bak negative versus Bak positive in transitional cell carcinoma (log-rank test p = 0.040).
The Journal of Urology  , DOI: ( /S (05)66332-X)
Copyright © 2001 American Urological Association, Inc. Terms and Conditions

5. Fig. 4
Kaplan-Meier disease-free survival curves for p53 40% or less versus p53 greater than 40% in squamous cell carcinoma (log-rank test p = ).
The Journal of Urology  , DOI: ( /S (05)66332-X)
Copyright © 2001 American Urological Association, Inc. Terms and Conditions

6. Fig. 5
Kaplan-Meier disease-free survival curves for p53 40% or less versus p53 greater than 40% in transitional cell carcinoma (log rank test p = ).
The Journal of Urology  , DOI: ( /S (05)66332-X)
Copyright © 2001 American Urological Association, Inc. Terms and Conditions

7. Fig. 6
Kaplan-Meier disease-free survival curves for p53 40% or less versus p53 greater than 40% in squamous cell carcinoma (log rank test p = ).
The Journal of Urology  , DOI: ( /S (05)66332-X)
Copyright © 2001 American Urological Association, Inc. Terms and Conditions

8. Fig. 7
Kaplan-Meier disease free-survival curves. A, grades 1 and 2 versus 3 in squamous cell carcinoma (log rank test p = 0.021). B, c-erbB-2 negative versus c-erbB-2 positive in transitional cell carcinoma (log rank test p = 0.036). C, Bcl-x negative versus Bcl-x positive in transitional cell carcinoma (log rank test p = 0.015). D, MIB-1 30% or less versus MIB-1 greater than 30% in transitional cell carcinoma (log rank test p = 0.034).
The Journal of Urology  , DOI: ( /S (05)66332-X)
Copyright © 2001 American Urological Association, Inc. Terms and Conditions